Production (Stage)
CalciMedica, Inc.
CALC
$1.70
-$0.02-1.16%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 2.27M | 2.34M | 2.19M | 2.37M | 2.82M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.50M | 6.17M | 5.74M | 6.53M | 5.77M |
| Operating Income | -6.50M | -6.17M | -5.74M | -6.53M | -5.77M |
| Income Before Tax | -5.04M | -4.26M | -5.62M | -3.95M | 130.00K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -5.04M | -4.26M | -5.62M | -3.95M | 130.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.04M | -4.26M | -5.62M | -3.95M | 130.00K |
| EBIT | -6.50M | -6.17M | -5.74M | -6.53M | -5.77M |
| EBITDA | -6.48M | -6.16M | -5.72M | -6.52M | -5.75M |
| EPS Basic | -0.36 | -0.33 | -0.50 | -0.36 | 0.01 |
| Normalized Basic EPS | -0.22 | -0.21 | -0.32 | -0.22 | 0.01 |
| EPS Diluted | -0.36 | -0.33 | -0.50 | -0.36 | 0.01 |
| Normalized Diluted EPS | -0.22 | -0.21 | -0.32 | -0.22 | 0.01 |
| Average Basic Shares Outstanding | 14.12M | 12.96M | 11.14M | 11.13M | 9.75M |
| Average Diluted Shares Outstanding | 14.12M | 12.96M | 11.14M | 11.13M | 10.05M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |